TICKERNOMICS Sign up
Last Update: 2024-03-28 02:11:25
ESTABLISHMENT LABS HOLDINGS INC. ( ESTA ) https://www.establishmentlabs.com
49.70USD
Sector:
Healthcare
Industry:
Medical Devices
Country:
Costa Rica
1y
3y
5y
10y
Historical Returns*:
SPY
31.15%
-27.62%
ESTA
SPY
32.74%
-14.38%
ESTA
SPY
92.93%
ESTA
106.74%
SPY
224.41%
ESTA
0.00%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
1274.10
1422.80
0.33
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-17.81
7.18
69.26
-7.78
0.00
-23.62
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
-54.64
67.66
-35.00
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
9.7531
-28.27
-43.88
1.47
Other Earnings and Cash Flow Stats:
ESTABLISHMENT LABS HOLDINGS INC. ( ESTA ) Net Income TTM ($MM) is -73.38
ESTABLISHMENT LABS HOLDINGS INC. ( ESTA ) Operating Income TTM ($MM) is -52.88
ESTABLISHMENT LABS HOLDINGS INC. ( ESTA ) Owners' Earnings Annual ($MM) is -100.28
ESTABLISHMENT LABS HOLDINGS INC. ( ESTA ) Current Price to Owners' Earnings ratio is -12.93
ESTABLISHMENT LABS HOLDINGS INC. ( ESTA ) EBITDA TTM ($MM) is -48.05
ESTABLISHMENT LABS HOLDINGS INC. ( ESTA ) EBITDA Margin is -35.00%
Capital Allocation:
ESTABLISHMENT LABS HOLDINGS INC. ( ESTA ) has paid 0.00 dividends per share and bought back -1.629387 million shares in the past 12 months
ESTABLISHMENT LABS HOLDINGS INC. ( ESTA ) has increased its debt by 9.39 million USD in the last 12 months
Capital Structure:
ESTABLISHMENT LABS HOLDINGS INC. ( ESTA ) Interest-bearing Debt ($MM) as of last quarter is 188
ESTABLISHMENT LABS HOLDINGS INC. ( ESTA ) Annual Working Capital Investments ($MM) are 12
ESTABLISHMENT LABS HOLDINGS INC. ( ESTA ) Book Value ($MM) as of last quarter is 18
ESTABLISHMENT LABS HOLDINGS INC. ( ESTA ) Debt/Capital as of last quarter is 1026%
Other Balance Sheet Stats:
ESTABLISHMENT LABS HOLDINGS INC. ( ESTA ) has 40 million in cash on hand as of last quarter
ESTABLISHMENT LABS HOLDINGS INC. ( ESTA ) has 57 million of liabilities due within 12 months, and long term debt 188 as of last quarter
ESTABLISHMENT LABS HOLDINGS INC. ( ESTA ) has 26 common shares outstanding as of last quarter
ESTABLISHMENT LABS HOLDINGS INC. ( ESTA ) has 0 million USD of preferred stock value
Academic Scores:
ESTABLISHMENT LABS HOLDINGS INC. ( ESTA ) Altman Z-Score is 1.56 as of last quarter
ESTABLISHMENT LABS HOLDINGS INC. ( ESTA ) Piotroski Score is 2.00 as of last quarter
Corporate Governance:
ESTABLISHMENT LABS HOLDINGS INC. ( ESTA ) largest shareholder is owning shares at 0.00 ($MM) value
Nicholas Sheridan Lewin(an insider) Bought 2000 shares of ESTABLISHMENT LABS HOLDINGS INC. ( ESTA ) for the amount of $54080.00 on 2023-12-14
12.35% of ESTABLISHMENT LABS HOLDINGS INC. ( ESTA ) is held by insiders, and 78.94% is held by institutions
ESTABLISHMENT LABS HOLDINGS INC. ( ESTA ) went public on 2018-07-19
Other ESTABLISHMENT LABS HOLDINGS INC. ( ESTA ) financial metrics:
FCF:-113.14
Unlevered Free Cash Flow:-91.55
EPS:-4.49
Operating Margin:-54.64
Gross Profit Margin:67.66
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:-636.54
Beta:1.47
Buffet's Owners Earnings:-100.28
Price to Owner's Earnings:-12.93
About ESTABLISHMENT LABS HOLDINGS INC. ( ESTA ) :
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.